Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CIPN Decision Aid to Improve Neurotoxic Chemotherapy Decision Making

NCT06915168 is registered in ClinicalTrials.gov with University of Michigan Rogel Cancer Center as lead sponsor.

NCT NCT06915168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06915168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CIPN Decision Aid to Improve Neurotoxic Chemotherapy Decision Making
Lead sponsor
University of Michigan Rogel Cancer Center
Phase
Not applicable
Overall status
Recruiting
Start date
November 13, 2024
Completion date
July 31, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma